A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...

Amadou Alpha Sall is a Senegalese virologist who worked for three decades at the Institut Pasteur de Dakar (IPD) before joining the Coalition for Epidemic Preparedness Innovations (CEPI), in 2025, as ...

Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...

The past 5 years have seen the strong momentum in youth engagement turn into many achievements worthy of celebration. When The Lancet Child & Adolescent Health launched its first Youth Advisory Panel ...

The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...

Bangladesh is experiencing a measles resurgence with unprecedented numbers of severe paediatric cases. As of March 30, 2026, nationwide deaths increased to at least 38 children, including 32 deaths in ...

Kidney disease is a major global health issue with implications for the lives of millions of people and for the cost of health care. Yet there is surprisingly little public awareness about the ...

The current global health financing emergency is not only creating a service delivery crisis;1 it threatens hard-won health research and life science ecosystems in low-income and middle-income ...

Despite data gaps in many countries, the burden of sickle cell disease, especially in west and central Africa, underscores ...

Despite substantial progress in malaria control over the past two decades, malaria caused by Plasmodium falciparum remains a leading cause of morbidity and mortality in sub-Saharan Africa, ...

We thank Ole Fröbert and colleagues for their interest in our study and proposing that vaccination might protect against cardiovascular disease through mechanisms beyond infection prevention, ...

Microplastics and nanoplastics (MNPs) are everywhere. These tiny particles—formed by abrasion, fragmentation, and open burning of plastics—are found in the ocean, the Arctic, Himalayan glaciers, air, ...